203 related articles for article (PubMed ID: 9395230)
41. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
42. High animal-fat intake changes the bile-acid composition of bile juice and enhances the development of Barrett's esophagus and esophageal adenocarcinoma in a rat duodenal-contents reflux model.
Chen KH; Mukaisho K; Sugihara H; Araki Y; Yamamoto G; Hattori T
Cancer Sci; 2007 Nov; 98(11):1683-8. PubMed ID: 17868414
[TBL] [Abstract][Full Text] [Related]
43. Risk for esophageal neoplasia in Barrett's esophagus patients with mucosal changes indefinite for dysplasia.
Horvath B; Singh P; Xie H; Thota PN; Allende DS; Pai RK; Patil DT; Plesec TP; Goldblum JR; Liu X
J Gastroenterol Hepatol; 2015 Feb; 30(2):262-7. PubMed ID: 25087917
[TBL] [Abstract][Full Text] [Related]
44. Bile acids but not acidic acids induce Barrett's esophagus.
Sun D; Wang X; Gai Z; Song X; Jia X; Tian H
Int J Clin Exp Pathol; 2015; 8(2):1384-92. PubMed ID: 25973022
[TBL] [Abstract][Full Text] [Related]
45. Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats.
Kumagai H; Mukaisho K; Sugihara H; Miwa K; Yamamoto G; Hattori T
Carcinogenesis; 2004 May; 25(5):723-7. PubMed ID: 14754873
[TBL] [Abstract][Full Text] [Related]
46. Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers.
Chen X; Qin R; Liu B; Ma Y; Su Y; Yang CS; Glickman JN; Odze RD; Shaheen NJ
BMC Gastroenterol; 2008 Jan; 8():1. PubMed ID: 18190713
[TBL] [Abstract][Full Text] [Related]
47. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
48. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
49. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
[TBL] [Abstract][Full Text] [Related]
50. Aberrant arachidonic acid metabolism in esophageal adenocarcinogenesis, and the effects of sulindac, nordihydroguaiaretic acid, and alpha-difluoromethylornithine on tumorigenesis in a rat surgical model.
Chen X; Li N; Wang S; Hong J; Fang M; Yousselfson J; Yang P; Newman RA; Lubet RA; Yang CS
Carcinogenesis; 2002 Dec; 23(12):2095-102. PubMed ID: 12507933
[TBL] [Abstract][Full Text] [Related]
51. Effect of freeze-dried berries on the development of reflux-induced esophageal adenocarcinoma.
Aiyer HS; Li Y; Losso JN; Gao C; Schiffman SC; Slone SP; Martin RC
Nutr Cancer; 2011 Nov; 63(8):1256-62. PubMed ID: 22043833
[TBL] [Abstract][Full Text] [Related]
52. Gastric juice protects against the development of esophageal adenocarcinoma in the rat.
Ireland AP; Peters JH; Smyrk TC; DeMeester TR; Clark GW; Mirvish SS; Adrian TE
Ann Surg; 1996 Sep; 224(3):358-70; discussion 370-1. PubMed ID: 8813264
[TBL] [Abstract][Full Text] [Related]
53. The use of dynamic positron emission tomography imaging for evaluating the carcinogenic progression of intestinal metaplasia to esophageal adenocarcinoma.
Li Y; Woodall C; Wo JM; Zheng H; Ng CK; Ray MB; Martin RC
Cancer Invest; 2008; 26(3):278-85. PubMed ID: 18317969
[TBL] [Abstract][Full Text] [Related]
54. Active matrix metalloproteases are expressed early on and are high during the Barrett's esophagus malignancy sequence.
Davelaar AL; Straub D; Buttar NS; Fockens P; Krishnadath KK
Scand J Gastroenterol; 2015 Mar; 50(3):321-32. PubMed ID: 25562781
[TBL] [Abstract][Full Text] [Related]
55. In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma.
Realdon S; Dassie E; Fassan M; Dall'Olmo L; Hatem G; Buda A; Arcidiacono D; Diamantis G; Zhang H; Greene MI; Sturniolo GC; Rugge M; Alberti A; Battaglia G
Dis Esophagus; 2015; 28(4):394-403. PubMed ID: 24708360
[TBL] [Abstract][Full Text] [Related]
56. A rat surgical model of esophageal metaplasia and adenocarcinoma-induced by mixed reflux of gastric acid and duodenal contents.
Zhang T; Zhang F; Han Y; Gu Z; Zhou Y; Cheng Q; Zhu Y; Zhang C; Wang Y
Dig Dis Sci; 2007 Nov; 52(11):3202-8. PubMed ID: 17393326
[TBL] [Abstract][Full Text] [Related]
57. High expression of Claudin-2 in esophageal carcinoma and precancerous lesions is significantly associated with the bile salt receptors VDR and TGR5.
Abu-Farsakh S; Wu T; Lalonde A; Sun J; Zhou Z
BMC Gastroenterol; 2017 Feb; 17(1):33. PubMed ID: 28212604
[TBL] [Abstract][Full Text] [Related]
58. Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation.
Woodall CE; Li Y; Liu QH; Wo J; Martin RC
Anticancer Drugs; 2009 Jul; 20(6):437-43. PubMed ID: 19398904
[TBL] [Abstract][Full Text] [Related]
59. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
[TBL] [Abstract][Full Text] [Related]
60. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
